Genetic regulation of embryonic head mesenchyme patterning
Genetic regulation of embryonic head mesenchyme patterning
批准号:
10228817
负责人:
Juhee Jeong
金额:
$24.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-01 至 2022-01-31
关键词:
AffectAgeApicalBirthBone platesBrainCalvariaCellsChIP-seqCompetenceCongenital AbnormalityCraniosynostosisDataDefectDermisDevelopmentDiagnosisEmbryoEmbryonic DevelopmentEquilibriumEyeFailureFrequenciesFrontal bone structureGenesGeneticGoalsHeadHeterotopic OssificationHomeoboxHumanInterventionJointsKnowledgeLateralLeadLinkLocationLong-Term EffectsMesenchymeMesodermMethodsMolecularMolecular GeneticsMorbidity - disease rateMusNeural CrestOperative Surgical ProceduresOsteogenesisOutcomeParietal bone structurePathogenesisPatternPhysiologic OssificationPositioning AttributePregnancyPreventionPrimary Cell CulturesPrimordiumPublic HealthRefractoryRegulationRegulatory ElementRepressionResearchRiskSideSignal TransductionSpecificitySurgical suturesTimeWNT Signaling Pathwaybasebonecell typecraniumdeep sequencinggenome-wideimprovedimproved outcomeindividualized medicineinnovationinsightmRNA sequencingmortalitymutantnovelorofacial developmentosteogenicoverexpressionprematurepreventprogramsregional differencesoft tissuetherapy outcometranscription factortranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The calvaria (upper part of the skull) comprises plates of bone and fibrous joints (sutures and fontanels), and
the balance between the two components is crucial. Craniosynostosis (premature loss of suture(s)) occurs at a
frequency of 1/2000 births, and it leads to a dysmorphic skull that can further affect brain and orofacial
development. Current treatment of craniosynostosis often involves invasive surgeries at young ages, with risks
for significant morbidity and even mortality. Therefore, improving the methods of intervention for this defect is
of great importance to public health. The long-term goal of our research is to obtain comprehensive
understanding of the molecular genetic regulation of calvarial development, which can lead to innovative
strategies to treat and prevent related birth defects.
During embryonic development, the head mesenchyme primordium of the calvaria completely encases
the brain from early stages. Subsequently, the calvarial bone starts to develop from the mesenchyme on the
lateral sides of the brain just above the eye (`supra-orbital' mesenchyme, SOM), and expands gradually toward
the vertex. In contrast, the mesenchyme positioned at the vertex from the beginning (`early migrating'
mesenchyme, EMM) does not initiate ossficiation, and contributes only to the soft tissue such as the sutures
and the dermis. This spatial restriction in bone formation is crucial to making the properly patterned calvaria
because it allows the vertex to be occupied by sutures and fontanels instead of bone. To date, little is known
about the factors that underlie this regional difference in the developmental program within the head
mesenchyme.
Based on our preliminary data, we hypothesize that EMM is intrinsically programmed to resist
osteogenic induction, and that LMX1B (LIM homeobox transcription factor 1b) is a key anti-osteogenic factor in
this context. Therefore, the goal of this proposal is to elucidate the molecular mechanism controlling the
osteogenic competence of EMM with a focus on LMX1B. We will define the spatial and temporal specificity of
LMX1B function during calvarial development, and investigate the effect of LMX1B on the function of
osteogenic signals. Furthermore, we will use genome-wide approaches to define the genetic programs specific
to EMM and SOM, and identify Lmx1b-downstream genetic network that regulates this patterning of the head
mesenchyme.
The outcome of our research will provide crucial insights into the regulation of early stages of calvarial
development and identify novel mechanisms and players that can contribute to the pathogenesis of
craniosynostosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic regulation of embryonic head mesenchyme patterning
-
批准号:9290041
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2017
-
负责人:Juhee Jeong
-
依托单位:
ROLE OF LDB1-LMX1B TRANSCRIPTION FACTOR COMPLEX IN CALVARIA DEVELOPMENT
-
批准号:8880178
-
项目类别:
-
资助金额:$11.89万
-
财政年份:2014
-
负责人:Juhee Jeong
-
依托单位:
Function and regulation of Lhx genes in craniofacial development
-
批准号:8201692
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:Juhee Jeong
-
依托单位:
Function and regulation of Lhx genes in craniofacial development
-
批准号:8383060
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2010
-
负责人:Juhee Jeong
-
依托单位:
Function and regulation of Lhx genes in craniofacial development
-
批准号:8209195
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2010
-
负责人:Juhee Jeong
-
依托单位:
Function and regulation of Lhx genes in craniofacial development
-
批准号:7571205
-
项目类别:
-
资助金额:$8.53万
-
财政年份:2009
-
负责人:Juhee Jeong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: